CellVoyant and Automata Announce Strategic Partnership to Deliver AI-Powered, Closed-Loop Cell Culture Optimisation

Automata LINQTM system at CellVoyant

CellVoyant and Automata have announced a strategic partnership to integrate FateDrive™ — CellVoyant’s AI-driven bioprocess optimisation platform — with Automata’s LINQ™ lab automation system.

This collaboration brings together advanced AI-powered predictive cell analytics and automated laboratory robotics to enable fully autonomous, closed-loop optimisation of cell culture workflows.

Accelerating AI-Driven Bioprocess Development

The partnership combines CellVoyant’s machine learning models — capable of predicting present and future cell states, critical quality attributes (CQAs), and experimental outcomes — with Automata’s programmable, scalable lab automation platform. Together, the integrated system enables:

  • Closed-loop cell culture optimisation driven by real-time AI insights
  • Automated experimental design and execution
  • Reduced trial-and-error process development
  • Faster identification of optimal culture conditions
  • Improved yields and reproducibility in cell-based manufacturing

By linking predictive modelling directly with automated experimentation, the platform continuously learns from experimental data, refines process parameters, and executes improved protocols without manual intervention.

Enabling Autonomous, Data-Informed Cell Culture Workflows

Traditional bioprocess development often relies on iterative experimentation, consuming time, materials, and resources. The CellVoyant–Automata integration replaces this approach with data-informed, AI-guided optimisation, supporting applications across:

  • Stem cell bioprocessing
  • Advanced cell therapies
  • Regenerative medicine manufacturing
  • Biopharmaceutical R&D

The result is a scalable, intelligent system designed to deliver earlier insights, fewer failed experiments, and more efficient cell-based development.

Driving the Future of AI-Powered Lab Automation

This strategic partnership represents a significant step toward fully autonomous laboratories, where artificial intelligence and robotics work together to accelerate scientific discovery and biomanufacturing innovation.

For the full press release, visit: https://www.automata.tech/company-news/automata-and-cellvoyant-announce-strategic-partnership-to-deliver-ai-powered-closed-loop-cell-culture-workflows

To learn more about FateDrive™ and the integrated workflow, you can request a call with our team.